Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.79 USD | -0.21% | -10.26% | +82.57% |
05-07 | Citigroup Starts Summit Therapeutics With Buy Rating, $7 Price Target | MT |
05-01 | Transcript : Summit Therapeutics Inc., Q1 2024 Earnings Call, May 01, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+82.57% | 3.37B | |
+3.88% | 111B | |
+11.47% | 105B | |
-12.66% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.31% | 16.96B | |
+2.90% | 13.7B | |
+36.77% | 12.45B |
- Stock Market
- Equities
- SMMT Stock
- News Summit Therapeutics Inc.
- Summit Therapeutics : HC Wainwright Downgrades Summit Therapeutics to Neutral from Buy